Calls for Proposals

Through Calls for Proposals, we find smart new ideas to help to alleviate the burden of diseases such as HIV/AIDS, tuberculosis and malaria, which often affect the poorest people in society.

Currently, no calls for proposals are open for applications. Are you looking for UnitaidExplore?

Closed Calls for Proposals

Closed
24 May 2021 at 12:00 noon CET

Accelerating tools to drive tuberculosis (TB) detection

Unitaid is pleased to announce a new Call for Proposals on the area for intervention: Accelerating tools to drive tuberculosis (TB) detection.

Learn More

Closed
7 April 2021 at 12:00 noon CET

Better tools to prevent and treat postpartum hemorrhage

Unitaid is pleased to announce a new Call for Proposals in the Area for Intervention: New tools for reducing maternal mortality.

Learn More

Closed
11 March 2020 12:00 noon CET

Intermittent Preventive Treatment in infants

Under this Call, Unitaid is soliciting proposals aimed at accelerating the adoption and scale-up of IPTi in moderate-to-high transmission settings.

Learn More

Closed
27 February 2020
17:00 CET

In maternal and child health. Towards the elimination of congenital infection in Chagas Disease through better tools for diagnosis and treatment

In the context of maternal and child health, Unitaid has identified the opportunity to support the elimination target of congenital transmission of Chagas disease in endemic countries.

Learn More

Closed
23 April 2019
12:00 noon CET

Accelerating impact of long-acting technologies in low- and middle-income countries

For the purpose of this call, Unitaid defines ‘long-acting products’ to mean sustained/extended release products that allow slow absorption of administered drugs maintaining their effects over long periods of time (i.e., over a week for oral products, over a month for injectables and other devices such as implants, patches or rings). The expected change in public health impact for the new products, compared to current daily oral formulations, would need to be explained in each case as it differs depending on disease and indication.

Learn More

Closed
17 April 2019
12:00 noon CET

Better tools for the diagnosis and treatment of Plasmodium vivax malaria

More than one-third of the world’s population – over 2.5 billion people – is at risk of Plasmodium vivax (P. vivax) malaria – the second most common species of malaria. P. vivax occurs in high burden countries but also accounts for over 70% of malaria cases in countries approaching elimination. It can cause severe disease and death, and represents a major financial burden to patients and their caregivers. High-risk groups include migrant populations, the rural poor, and other marginalized groups, as well as children under 5 who have the greatest chance of suffering negative health consequences as a result of their infection.

Learn More

Closed
17 August 2018
12:00 noon CET

Better tools for integrated management of childhood fever

Under this Call, Unitaid is soliciting proposals for the following interventions aimed at accelerating the availability, adoption and scale-up of improved tools to identify severe disease.

Learn More

Closed
27 August 2018
12:00 noon CET

Preventing deaths from cervical cancer

Unitaid seeks to widen access to the best tools for cervical cancer prevention in low- and middle-income countries.

Learn More

Sign Up for Unitaid Updates

  • This field is for validation purposes and should be left unchanged.